ReviewCurrent opinion in pharmacology2022

The mechanistic target of rapamycin as a regulator of metabolic function in oligodendroglia during remyelination.

Marie L Mather et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.